Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 606 across all filing types
Latest filing 2024-01-19 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Share Issue/Capital Change Classification · 1% confidence The document is identified by the header 'RNS Number : 3503A' and contains information about an 'Application for Listing' of new ordinary shares due to a deferred remuneration award. It explicitly mentions the expected admission date and confirms the new total voting rights figure, which is crucial for shareholders under FCA rules. The presence of the RNS distribution tracker and the concluding statement about RNS being the news service of the London Stock Exchange strongly indicates this is a regulatory announcement disseminated via the RNS system. Since the content specifically deals with the issuance of new shares and the resulting change in total voting rights, it fits the 'Share Issue/Capital Change' (SHA) category best, although it is distributed via RNS. Given the specific nature of the share issuance and capital structure update, SHA is more precise than the general RNS fallback. The document length is short (3933 chars), but the content is a substantive announcement, not just a notice that a report is attached, thus it is not an RPA.
2024-01-19 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is clearly identified as an 'RNS Number' announcement from 'genedrive plc' dated 15 January 2024. The content discusses an 'Application for Listing' of new ordinary shares to support an Equity Prepayment facility and confirms the 'Total Voting Rights' after the expected admission. This is a regulatory announcement concerning share capital changes and listing details. While it relates to share capital (SHA), the primary function here is a formal regulatory disclosure via the RNS system, which often serves as a general regulatory filing announcement. Given the context of the RNS header and the nature of the announcement (a formal update to the market regarding share issuance and total voting rights), it fits best under the general regulatory announcement category (RNS), as it is not a detailed report itself, but a notification of an event. However, since it specifically details the issuance of new shares and the resulting total share count, 'Share Issue/Capital Change' (SHA) is also highly relevant. Since the document explicitly mentions the application for admission of new shares and updates the total voting rights denominator, SHA is the most specific fit for the core corporate action described, even though it is delivered via RNS.
2024-01-15 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the header 'RNS Number' and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content announces an 'Application for Listing' of new ordinary shares related to an existing equity facility, confirming the total voting rights post-admission. This is a formal regulatory announcement concerning share capital changes and admission to trading. While it relates to share capital (SHA), the primary nature of this specific filing, distributed via RNS, is a general regulatory announcement. Given the context of RNS distribution and the nature of the announcement (new shares admitted to trading), it fits best under the general regulatory filing category (RNS) or potentially Share Issue/Capital Change (SHA). Since it is a formal notification distributed through the official regulatory news service (RNS) and deals with the mechanics of share admission rather than just the issuance itself, RNS is a strong candidate, but SHA is also highly relevant. However, the text explicitly mentions the RNS distribution service and the structure is typical of a broad regulatory update. Given the options, and that it is a formal notification of a corporate action distributed via the official channel, RNS is appropriate, but SHA (Share Issue/Capital Change) is more specific to the content (new shares being admitted). Since the content is about the admission of new shares and the resulting total voting rights, SHA is the most precise fit among the specific codes, although RNS is the distribution mechanism.
2024-01-10 English
Equity Prepayment Facility drawdown
Share Issue/Capital Change Classification · 1% confidence The document is clearly identified as an RNS announcement (RNS Number : 2580Y) from Genedrive PLC, dated 02 January 2024. The content details a financial transaction: a scheduled draw down under an Equity Prepayment Facility and the issuance of warrants. This is a specific corporate action announcement. While it relates to capital ('CAP'), the format and source (RNS, regulated by the FCA) strongly suggest it is a general regulatory disclosure. Since it is not a full report (like 10-K or IR) and is a specific, time-sensitive announcement distributed via the official news service, it fits best under the general regulatory filing category, RNS, which serves as the fallback for specific announcements not covered by other codes like DIV, SHA, or CAP (which usually implies a larger financing event or structural change, whereas this is a drawdown notice). Given the explicit mention of 'RNS Number' and the standard footer information provided by RNS, the classification RNS is appropriate.
2024-01-02 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states it is announcing the 'Result of AGM' (Annual General Meeting). It details that 'all resolutions proposed were duly passed' and provides a table showing the 'proxy voting' results for each resolution. This content directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, and specifically, the results of voting are a key component of AGM outcomes. Although it contains voting results (DVA), the context is explicitly tied to the AGM event itself, making AGM-R the most precise fit for the overall announcement.
2023-12-29 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the header 'RNS Number' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces an 'Application for Listing' of new ordinary shares related to drawing down an Equity Prepayment facility, confirming the total voting rights after the admission. This is a formal regulatory announcement concerning share capital changes and admission to trading. While it relates to share capital (SHA), the primary function here is the official notification of this corporate action via the RNS system, which often defaults to the general regulatory filing category if a more specific one like SHA or CAP doesn't perfectly capture the nature of the announcement itself. However, since it directly details the issuance of new shares and the resulting total voting rights, it strongly aligns with 'Share Issue/Capital Change' (SHA). Given the context of an RNS announcement detailing a specific share issuance for financing purposes, SHA is the most precise fit over the general RNS fallback.
2023-12-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.